HRV vaccine (human rotavirus vaccine) 444563
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HRV vaccine (human rotavirus vaccine) 444563, covering 2019-10-14 to 2019-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks [Phase 3]